For nearly two years, a patent dispute quietly erased a health feature from millions of American wrists — a reminder that the tools we come to rely on exist within legal and commercial ecosystems as much as technological ones. Apple has now restored blood oxygen monitoring to its newest US Apple Watch models through a software update that shifts the computational work from watch to iPhone, satisfying import restrictions while returning a capability many users had come to depend on. The resolution, enabled by a fresh US Customs ruling, closes a chapter that began in 2023 when the International
Apple restores blood oxygen feature via iOS 18.6.1 workaround after patent dispute
Cobertura Relacionada
A federal judge ruled the Trump administration unconstitutionally punished AI firm Anthropic for protected speech by cut…
NPR · Aug 28 Judge rules Pentagon's retaliation against Anthropic over AI criticism illegalA federal judge ruled Thursday that the Pentagon illegally punished AI company Anthropic for criticizing the Department …
Manila Bulletin · Aug 28 Lucena inventor demonstrates trash-collecting robot made from recycled materialsAn electronics technician in Lucena City created a remote-controlled garbage-collecting robot from recycled materials to…
The Guardian · Aug 28 Federal judge strikes down Pentagon's unlawful blacklisting of AI firm AnthropicA federal judge ruled the Trump administration's sanctions against AI company Anthropic were illegal retaliation for cri…
Sesgo y Encuadre
Article presents Apple's workaround favorably with minimal critical analysis of patent dispute implications or Masimo's perspective.
Apple-centric narrative framing the workaround as a positive 'restoration' and 'latest development' without substantive examination of the underlying patent dispute merit or competitor impact.
Impacto Geopolítico
Apple circumvents US patent ban on blood oxygen feature by processing data on iPhones instead of watches, restoring functionality through software workaround.
Demonstrates corporate adaptation to regulatory enforcement; highlights tension between innovation and intellectual property protection. Masimo's patent victory shows smaller health-tech firms can challenge tech giants, but Apple's workaround illustrates how large corporations can engineer solutions to maintain market presence despite legal restrictions.
Similar to pharmaceutical companies reformulating drugs to circumvent patent expirations or restrictions—legal workarounds that maintain competitive advantage while respecting regulatory boundaries.
Lente Económico
Apple circumvents patent dispute ban by processing blood oxygen data on iPhones instead of watches, restoring functionality to US Apple Watch models through software workaround.
US Apple Watch owners regain blood oxygen monitoring capability, though with reduced convenience (data viewed on iPhone Health app rather than watch display). Existing feature parity restored without hardware replacement, maintaining customer satisfaction and ecosystem lock-in.
Demonstrates regulatory workarounds in patent disputes; may prompt ITC to clarify enforcement mechanisms for software-based solutions. Could influence future patent litigation strategy in tech sector, particularly regarding data processing location requirements in import ban enforcement.